Drug profile · INN
alpha-1-antitrypsin
INFINIA
alpha-1-antitrypsin (INFINIA) is a leukocyte elastase inhibitor.
EMA: application withdrawn Blood and blood forming organs (B02) B02AB02
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — alpha-1-antitrypsin
- Class
- Blood and blood forming organs (B02)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
alpha-1-antitrypsin (INFINIA) is a leukocyte elastase inhibitor.
Key facts
INN alpha-1-antitrypsin
Brand INFINIA
Mechanism Leukocyte elastase inhibitor
Target Neutrophil elastase
Therapeutic class Blood and blood forming organs (B02)
ATC code B02AB02
Mechanism of action
Leukocyte elastase inhibitor
Primary target: Neutrophil elastase
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | application withdrawn | — |
Related & competitor drugs
Frequently asked questions
What is alpha-1-antitrypsin?
alpha-1-antitrypsin (INFINIA) is a leukocyte elastase inhibitor.
What is the brand name for alpha-1-antitrypsin?
INFINIA is a marketed brand name for alpha-1-antitrypsin. Check FDA Drugs@FDA for the current US label holder and prescribing information.